Reactivation of hepatitis B virus following bendamustine-containing chemotherapy in a patient with multiple myeloma

Leukemia and Lymphoma

Volumn 52, Issue 5, 2011, Pages 916-918

  Tapan, Umit ^a   May, Sarah K ^a   Fiore, Joseph ^a   Kozyreva, Olga ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; BENDAMUSTINE; BILIRUBIN; BILIRUBIN GLUCURONIDE; BORTEZOMIB; CYCLOPHOSPHAMIDE; DEXAMETHASONE; ENTECAVIR; HEPATITIS B(E) ANTIBODY; LENALIDOMIDE; TANESPIMYCIN; THALIDOMIDE;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANTIBODY BLOOD LEVEL; ARTICLE; BILIRUBIN BLOOD LEVEL; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CASE REPORT; CAUSE OF DEATH; DISEASE EXACERBATION; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FULMINANT HEPATIC FAILURE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; INTERNATIONAL NORMALIZED RATIO; JAUNDICE; LIVER FUNCTION; MALE; MULTIPLE CYCLE TREATMENT; MULTIPLE MYELOMA; NEUROPATHY; PRIORITY JOURNAL; SALVAGE THERAPY; SEROLOGY; THROMBOCYTOPENIA; TREATMENT RESPONSE; VIRUS LOAD; VIRUS REACTIVATION;

ANTINEOPLASTIC AGENTS; HEPATITIS B VIRUS; HUMANS; MALE; MIDDLE AGED; MULTIPLE MYELOMA; NITROGEN MUSTARD COMPOUNDS; VIRUS ACTIVATION;

EID: 79955063562     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2010.551573     Document Type: Article

References (14)

1. Lok AS, Liang RH, Chiu EK, Wong KL, Chan TK, Todd D. Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Report of a prospective study. Gastroenterology 1991;100:182-188.
2. Coiffier B. Hepatitis B virus reactivation in patients receiving chemotherapy for cancer treatment: role of lamivudine prophylaxis. Cancer Invest 2006;24:548-552. (Pubitemid 44576409)
3. Tsutsumi Y, Kanamori H, Mori A, et al. Reactivation of hepatitis B virus with rituximab. Expert Opin Drug Saf 2005;4:599-608. (Pubitemid 40723731)
4. Yeo W, Chan TC, Leung NW, et al. Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without rituximab. J Clin Oncol 2009;27:605-611.
5. Beysel S, Yegin ZA, Yagci M. Bortezomib-associated late hepatitis B reactivation in a case of multiple myeloma. Turk J Gastroenterol 2010;21:197-198.
6. Perceau G, Diris N, Estines O, Derancourt C, Lévy S, Bernard P. Late lethal hepatitis B virus reactivation after rituximab treatment of low-grade cutaneous B-cell lymphoma. Br J Dermatol 2006;155:1053-1056. (Pubitemid 44564520)
7. Picardi M, Pane F, Quintarelli C, et al. Hepatitis B virus reactivation after fludarabine-based regimens for indolent non-Hodgkin's lymphomas: high prevalence of acquired viral genomic mutations. Haematologica 2003;88:1296-1303. (Pubitemid 37456385)
8. Dennie TW, Kolesar JM. Bendamustine for the treatment of chronic lymphocytic leukemia and rituximab-refractory, indolent B-cell non-Hodgkin lymphoma. Clin Ther 2009;31: 2290-2311.
9. Kath R, Blumenstengel K, Fricke HJ, Höffken K. Bendamustine monotherapy in advanced and refractory chronic lymphocytic leukemia. J Cancer Res Clin Oncol 2001;127:48-54.
10. Klippstein A, Schneider CP, Sayer HG, Höffken K. Pneumocystis carinii pneumonia as a complication of bendamustine monotherapy in a patient with advanced progressive breast cancer. J Cancer Res Clin Oncol 2003;129:316-319. (Pubitemid 36791688)
11. American Association for the Study of Liver Diseases practice guidelines: chronic hepatitis B: update 2009 [Internet]. [Cited 28 October 2010]. Available from: http://www.aasld.org/practiceguidelines/.
12. Centers for Disease Control and Prevention: recommendations for identification and public health management of persons with chronic hepatitis B virus infection [Internet]. [Cited 28 October 2010]. Available from: http://www.cdc.gov/
13. Artz AS, Somerfield MR, Feld J, et al. American Society of Clinical Oncology provisional clinical opinion: chronic hepatitis B virus infection screening in patients receiving cytotoxic chemotherapy for treatment of malignant diseases. J Clin Oncol 2010;28:3199-3202.
14. Recruiting, completed and active but not recruiting clinical trials with bendamustine [Internet]. Bethesda, MA: Clinical-Trials.gov registry [cited 28 October 2010]. Available from: http://clinicaltrials.gov/